TrialAmerican heart journal2009

Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.

Matteo Cesari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.